Trump’s Executive Orders on Drug Pricing: The Drug Channels Guide to Industry Implications

Surprise! President Trump signed four executive orders (EO) last Friday afternoon. They cover:
Pass-through of 340B discounts for insulin and EpiPens
Rebate reform (!)
Importation
Most Favored Nation (MFN) pricing for drugs
The fourth order on MFN has not been publicly released, so I will reserve comment for now.

I see significant challenges in implementing these far-reaching orders. Below, you’ll find the text of the first three along with my commentary and links to Drug Channels articles that will help you make sense of them.